scispace - formally typeset
A

Atilla Icli

Researcher at Ahi Evran University

Publications -  51
Citations -  822

Atilla Icli is an academic researcher from Ahi Evran University. The author has contributed to research in topics: Mean platelet volume & Platelet activation. The author has an hindex of 17, co-authored 51 publications receiving 722 citations. Previous affiliations of Atilla Icli include Süleyman Demirel University.

Papers
More filters
Journal ArticleDOI

Mean platelet volume in patients with prehypertension and hypertension

TL;DR: It is shown that, MPV, an indicator of platelet activation was significantly higher in patients with prehypertension and hypertension when compared with control subjects, and was also higher in hypertensives than inPrehypertensives, and the presence of the hypertension was only significant predictor of higher MPV.
Journal ArticleDOI

Effect of Smoking Cessation on Mean Platelet Volume

TL;DR: Serum MPV values were significantly higher in regular smokers than in controls and the effect of smoking cessation on MPV decreased significantly at 3 months after smoking cessation.
Journal ArticleDOI

Metoprolol vs. carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study.

TL;DR: Carvedilol plus NAC decreased POAF incidence and duration of hospitalization compared with metoprolol and decreasedPOAF incidence compared with carvedilol.
Journal ArticleDOI

Effects of normal blood pressure, prehypertension, and hypertension on autonomic nervous system function.

TL;DR: It was found that systolic BP, postprandial glucose level and exercise duration were independent predictors of lower HRR, and the subjects with PHT had HRR as lower as patients with HT did, supportive for the hypothesis that autonomic dysregulation is present in an early stage of essential hypertension.
Journal ArticleDOI

Effects of Allopurinol on Coronary Microvascular and Left Ventricular Function in Patients With Idiopathic Dilated Cardiomyopathy

TL;DR: 3-month treatment with allopurinol was significantly associated with reduced UA levels, and improvement of CFR and LV functions in patients with idiopathic dilated cardiomyopathy and hyperuricemia.